BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 53.0] [Reference Citation Analysis]
Number Citing Articles
1 Alberici F, Affatato S, Moratto D, Mescia F, Delbarba E, Guerini A, Tedesco M, Burbelo PD, Zani R, Castagna I, Gallico A, Tonoli M, Venturini M, Roccaro AM, Giacomelli M, Cohen JI, Giustini V, Dobbs K, Su HC, Fiorini C, Quaresima V, Viola FB, Vizzardi V, Gaggiotti M, Bossini N, Gaggia P, Badolato R, Notarangelo LD, Chiarini M, Scolari F. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response. J Nephrol. [DOI: 10.1007/s40620-021-01214-8] [Reference Citation Analysis]
2 Winchester N, Calabrese C, Calabrese LH. The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding? Pathog Immun 2021;6:31-54. [PMID: 33969248 DOI: 10.20411/pai.v6i1.417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Rossano R, Larocca M, Macellaro M, Bilancia D, Riccio P. Unveiling a Hidden Biomarker of Inflammation and Tumor Progression: The 65 kDa Isoform of MMP-9 New Horizons for Therapy. CIMB 2022;44:105-16. [DOI: 10.3390/cimb44010008] [Reference Citation Analysis]
4 Schweizer TA, Mairpady Shambat S, Vulin C, Hoeller S, Acevedo C, Huemer M, Gomez‐mejia A, Chang C, Baum J, Hertegonne S, Hitz E, Scheier TC, Hofmaenner DA, Buehler PK, Moch H, Schuepbach RA, Brugger SD, Zinkernagel AS. Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients. Clin & Trans Imm 2021;10. [DOI: 10.1002/cti2.1357] [Reference Citation Analysis]
5 Catteeuw JV, DiNubile MJ. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia. Clin Infect Pract 2021;12:100088. [PMID: 34396087 DOI: 10.1016/j.clinpr.2021.100088] [Reference Citation Analysis]
6 Liang X, Chen Y, Fan Y. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma. Environ Sci Pollut Res Int 2021. [PMID: 34775559 DOI: 10.1007/s11356-021-17321-9] [Reference Citation Analysis]
7 Sidhom JW, Baras AS. Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires. Sci Rep 2021;11:14275. [PMID: 34253751 DOI: 10.1038/s41598-021-93608-8] [Reference Citation Analysis]
8 Diorio C, Shraim R, Vella LA, Giles JR, Baxter AE, Oldridge DA, Canna SW, Henrickson SE, McNerney KO, Balamuth F, Burudpakdee C, Lee J, Leng T, Farrel A, Lambert MP, Sullivan KE, Wherry EJ, Teachey DT, Bassiri H, Behrens EM. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction. Nat Commun 2021;12:7222. [PMID: 34893640 DOI: 10.1038/s41467-021-27544-6] [Reference Citation Analysis]
9 Won T, Wood MK, Hughes DM, Talor MV, Ma Z, Schneider J, Skinner JT, Asady B, Goerlich E, Halushka MK, Hays AG, Kim DH, Parikh CR, Rosenberg AZ, Coppens I, Johns RA, Gilotra NA, Hooper JE, Pekosz A, Čiháková D. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine 2022;75:103812. [PMID: 35033854 DOI: 10.1016/j.ebiom.2022.103812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sahoo D, Katkar GD, Khandelwal S, Behroozikhah M, Claire A, Castillo V, Tindle C, Fuller M, Taheri S, Rogers TF, Beutler N, Ramirez SI, Rawlings SA, Pretorius V, Smith DM, Burton DR, Alexander LEC, Duran J, Crotty S, Dan JM, Das S, Ghosh P. AI-guided discovery of the invariant host response to viral pandemics. bioRxiv 2021:2020. [PMID: 32995790 DOI: 10.1101/2020.09.21.305698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Rizo-Téllez SA, Méndez-García LA, Rivera-Rugeles AC, Miranda-García M, Manjarrez-Reyna AN, Viurcos-Sanabria R, Solleiro-Villavicencio H, Becerril-Villanueva E, Carrillo-Ruíz JD, Cota-Arce JM, Álvarez-Lee A, De León-Nava MA, Escobedo G. The Combined Use of Cytokine Serum Values with Laboratory Parameters Improves Mortality Prediction of COVID-19 Patients: The Interleukin-15-to-Albumin Ratio. Microorganisms 2021;9:2159. [PMID: 34683480 DOI: 10.3390/microorganisms9102159] [Reference Citation Analysis]
12 Mahler M, Meroni PL, Infantino M, Buhler KA, Fritzler MJ. Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Rev Clin Immunol 2021;17:431-43. [PMID: 33750254 DOI: 10.1080/1744666X.2021.1905526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Mo S, Dai L, Wang Y, Song B, Yang Z, Gu W. Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID-19. Oxid Med Cell Longev 2021;2021:9998697. [PMID: 34457122 DOI: 10.1155/2021/9998697] [Reference Citation Analysis]
14 Sánchez-Marteles M, Rubio-Gracia J, Peña-Fresneda N, Garcés-Horna V, Gracia-Tello B, Martínez-Lostao L, Crespo-Aznárez S, Pérez-Calvo JI, Giménez-López I. Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection. J Clin Med 2021;10:3534. [PMID: 34441830 DOI: 10.3390/jcm10163534] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
16 Petzer V, Schwendinger S, Haschka D, Vogi V, Tymoszuk P, Burkert F, Sahanic S, Sonnweber T, Bellmann-Weiler R, Loeffler-Ragg J, Tancevski I, Zschocke J, Weiss G, Wolf D, Jukic E. Clonal hematopoiesis in patients with Covid-19 is stable and not linked to an aggravated clinical course. Am J Hematol 2021;96:E331-3. [PMID: 34028864 DOI: 10.1002/ajh.26251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Penttilä PA, Van Gassen S, Panovska D, Vanderbeke L, Van Herck Y, Quintelier K, Emmaneel A, Filtjens J, Malengier-Devlies B, Ahmadzadeh K, Van Mol P, Borràs DM, Antoranz A, Bosisio FM, Wauters E, Martinod K, Matthys P, Saeys Y, Garg AD, Wauters J, De Smet F; CONTAGIOUS consortium. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients. Cell Mol Life Sci 2021;78:3987-4002. [PMID: 33715015 DOI: 10.1007/s00018-021-03808-8] [Reference Citation Analysis]
18 Declercq J, Van Damme KFA, De Leeuw E, Maes B, Bosteels C, Tavernier SJ, De Buyser S, Colman R, Hites M, Verschelden G, Fivez T, Moerman F, Demedts IK, Dauby N, De Schryver N, Govaerts E, Vandecasteele SJ, Van Laethem J, Anguille S, van der Hilst J, Misset B, Slabbynck H, Wittebole X, Liénart F, Legrand C, Buyse M, Stevens D, Bauters F, Seys LJM, Aegerter H, Smole U, Bosteels V, Hoste L, Naesens L, Haerynck F, Vandekerckhove L, Depuydt P, van Braeckel E, Rottey S, Peene I, Van Der Straeten C, Hulstaert F, Lambrecht BN. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. Lancet Respir Med 2021:S2213-2600(21)00377-5. [PMID: 34756178 DOI: 10.1016/S2213-2600(21)00377-5] [Reference Citation Analysis]
19 Buszko M, Nita-Lazar A, Park JH, Schwartzberg PL, Verthelyi D, Young HA, Rosenberg AS. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol 2021;22:404-11. [PMID: 33723418 DOI: 10.1038/s41590-021-00901-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
20 Ramandi A, Akbarzadeh MA, Khaheshi I, Khalilian MR. Aortic dissection and Covid-19; a comprehensive systematic review. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101129] [Reference Citation Analysis]
21 Stack M, Sacco K, Castagnoli R, Livinski AA, Notarangelo LD, Lionakis MS. BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review. Res Sq 2021:rs. [PMID: 33791689 DOI: 10.21203/rs.3.rs-319342/v1] [Reference Citation Analysis]
22 Stoy N. Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19. Front Immunol 2021;12:638446. [PMID: 33936053 DOI: 10.3389/fimmu.2021.638446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yin M, Nie Y, Liu H, Liu L, Tang L, Dong Y, Hu C, Wang H. Development of a europium nanoparticles lateral flow immunoassay for NGAL detection in urine and diagnosis of acute kidney injury. BMC Nephrol 2022;23:30. [PMID: 35031018 DOI: 10.1186/s12882-021-02493-w] [Reference Citation Analysis]
24 Liu C, Martins AJ, Lau WW, Rachmaninoff N, Chen J, Imberti L, Mostaghimi D, Fink DL, Burbelo PD, Dobbs K, Delmonte OM, Bansal N, Failla L, Sottini A, Quiros-Roldan E, Han KL, Sellers BA, Cheung F, Sparks R, Chun TW, Moir S, Lionakis MS, Rossi C, Su HC, Kuhns DB, Cohen JI, Notarangelo LD, Tsang JS; NIAID COVID Consortium., COVID Clinicians. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 2021;184:1836-1857.e22. [PMID: 33713619 DOI: 10.1016/j.cell.2021.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
25 Sahoo D, Katkar GD, Khandelwal S, Behroozikhah M, Claire A, Castillo V, Tindle C, Fuller M, Taheri S, Rogers TF, Beutler N, Ramirez SI, Rawlings SA, Pretorius V, Smith DM, Burton DR, Alexander LEC, Duran J, Crotty S, Dan JM, Das S, Ghosh P. AI-guided discovery of the invariant host response to viral pandemics. EBioMedicine 2021;68:103390. [PMID: 34127431 DOI: 10.1016/j.ebiom.2021.103390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Chun HJ, Coutavas E, Pine A, Lee AI, Yu V, Shallow M, Giovacchini CX, Mathews A, Stephenson B, Que LG, Lee PJ, Kraft BD. Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC). medRxiv 2021:2021. [PMID: 33564789 DOI: 10.1101/2021.01.31.21250870] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
27 Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M; Uppsala Intensive Care COVID-19 Research Group. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine 2022;149:155727. [PMID: 34628127 DOI: 10.1016/j.cyto.2021.155727] [Reference Citation Analysis]
28 Moser D, Biere K, Han B, Hoerl M, Schelling G, Choukér A, Woehrle T. COVID-19 Impairs Immune Response to Candida albicans. Front Immunol 2021;12:640644. [PMID: 33717195 DOI: 10.3389/fimmu.2021.640644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yessayan LT, Neyra JA, Westover AJ, Szamosfalvi B, Humes HD. Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients. Critical Care Explorations 2022;4:e0694. [DOI: 10.1097/cce.0000000000000694] [Reference Citation Analysis]
30 Youssry I, Abd Elaziz D, Ayad N, Eyada I. The Cause–Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic. Hematology Reports 2022;14:95-102. [DOI: 10.3390/hematolrep14020014] [Reference Citation Analysis]
31 Kanimozhi G, Pradhapsingh B, Singh Pawar C, Khan HA, Alrokayan SH, Prasad NR. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Front Pharmacol 2021;12:638334. [PMID: 33967772 DOI: 10.3389/fphar.2021.638334] [Reference Citation Analysis]
32 Hardy E, Fernandez-Patron C. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis. Biomolecules 2021;11:390. [PMID: 33800947 DOI: 10.3390/biom11030390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Fonseca W, Asai N, Yagi K, Malinczak C, Savickas G, Johnson CC, Murray S, Zoratti EM, Lukacs NW, Li J, Schuler Iv CF. COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males. Viruses 2021;13:2415. [DOI: 10.3390/v13122415] [Reference Citation Analysis]
34 Morton B, Barnes KG, Anscombe C, Jere K, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda N, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC. In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles. medRxiv 2021:2021. [PMID: 33619502 DOI: 10.1101/2021.02.15.21251753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Lee AC, Castaneda G, Li WT, Chen C, Shende N, Chakladar J, Taub PR, Chang EY, Ongkeko WM. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation. Viruses 2021;13:1018. [PMID: 34071557 DOI: 10.3390/v13061018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Russick J, Foy PE, Josseaume N, Meylan M, Hamouda NB, Kirilovsky A, Sissy CE, Tartour E, Smadja DM, Karras A, Hulot JS, Livrozet M, Fayol A, Arlet JB, Diehl JL, Dragon-Durey MA, Pagès F, Cremer I. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol 2021;12:701273. [PMID: 34322128 DOI: 10.3389/fimmu.2021.701273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Morton B, Barnes KG, Anscombe C, Jere K, Matambo P, Mandolo J, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda NP, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC; Blantyre COVID-19 Consortium. Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa. Nat Commun 2021;12:3554. [PMID: 34117221 DOI: 10.1038/s41467-021-23267-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Deng J, Golub LM, Lee HM, Raja V, Johnson F, Kucine A, Lee W, Xu TM, Gu Y. A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis. J Inflamm Res 2021;14:5337-47. [PMID: 34703272 DOI: 10.2147/JIR.S330157] [Reference Citation Analysis]
39 Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, Lasinio GJ, Álvarez-Sierra D, Kiernan CH, Castro Eiro MD, van Meurs M, Brouwers-Haspels I, Zhao M, Li L, de Wit H, Ouzounis CA, Wilmsen MEP, Alofs TM, Laport DA, van Wees T, Kraker G, Jaimes MC, Van Bockstael S, Hernández-González M, Rokx C, Rijnders BJA, Pujol-Borrell R, Katsikis PD. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nat Commun 2022;13:915. [PMID: 35177626 DOI: 10.1038/s41467-022-28621-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
40 Wendt R, Thijs L, Kalbitz S, Mischak H, Siwy J, Raad J, Metzger J, Neuhaus B, Leyen HV, Dudoignon E, Mebazaa A, Spasovski G, Milenkova M, Canevska-Talevska A, Czerwieńska B, Wiecek A, Peters B, Nilsson Å, Schwab M, Rothfuss K, Lübbert C, Staessen JA, Beige J; CRIT-COV-U investigators. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients. EClinicalMedicine 2021;36:100883. [PMID: 33969282 DOI: 10.1016/j.eclinm.2021.100883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Alshammary AF, Alsughayyir JM, Alharbi KK, Al-sulaiman AM, Alshammary HF, Alshammary HF. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med 2022;9:852749. [DOI: 10.3389/fmed.2022.852749] [Reference Citation Analysis]
42 Hattori T, Iwasaki-Hozumi H, Bai G, Chagan-Yasutan H, Shete A, Telan EF, Takahashi A, Ashino Y, Matsuba T. Both Full-Length and Protease-Cleaved Products of Osteopontin Are Elevated in Infectious Diseases. Biomedicines 2021;9:1006. [PMID: 34440210 DOI: 10.3390/biomedicines9081006] [Reference Citation Analysis]
43 Mohammed Y, Goodlett DR, Cheng MP, Vinh DC, Lee TC, Mcgeer A, Sweet D, Tran K, Lee T, Murthy S, Boyd JH, Singer J, Walley KR, Patrick DM, Quan C, Ismail S, Amar L, Pal A, Bassawon R, Fesdekjian L, Gou K, Lamontagne F, Marshall J, Haljan G, Fowler R, Winston BW, Russell JA; ARBs CORONA I. Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19. J Proteome Res 2022. [PMID: 35143212 DOI: 10.1021/acs.jproteome.1c00863] [Reference Citation Analysis]
44 Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. J Hematol Oncol 2022;15:5. [PMID: 35012610 DOI: 10.1186/s13045-021-01222-y] [Reference Citation Analysis]
45 Sattar Z, Lora A, Jundi B, Railwah C, Geraghty P. The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases. Pulm Med 2021;2021:5488591. [PMID: 34239729 DOI: 10.1155/2021/5488591] [Reference Citation Analysis]
46 Nieri D, Neri T, Barbieri G, Moneta S, Morelli G, Mingardi D, Spinelli S, Ghiadoni L, Falcone M, Tiseo G, Menichetti F, Franzini M, Caponi L, Paolicchi A, Pancani R, Pistelli F, Carrozzi L, Celi A; Pisa COVID group. C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study. Thromb Res 2021;204:88-94. [PMID: 34153649 DOI: 10.1016/j.thromres.2021.06.003] [Reference Citation Analysis]
47 Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival. IDR 2022;Volume 15:821-9. [DOI: 10.2147/idr.s348392] [Reference Citation Analysis]
48 Declercq J, De Leeuw E, Lambrecht BN. Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: From prognostic marker to therapeutic agent. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155934] [Reference Citation Analysis]
49 Thompson MW. Regulation of zinc-dependent enzymes by metal carrier proteins. Biometals 2022. [PMID: 35192096 DOI: 10.1007/s10534-022-00373-w] [Reference Citation Analysis]
50 Abers MS, Rosen LB, Delmonte OM, Shaw E, Bastard P, Imberti L, Quaresima V, Biondi A, Bonfanti P, Castagnoli R, Casanova JL, Su HC, Notarangelo LD, Holland SM, Lionakis MS. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19. Immunol Cell Biol 2021. [PMID: 34309902 DOI: 10.1111/imcb.12495] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
51 Li J, Wei J, Xu Z, Jiang C, Li M, Chen J, Li Y, Yang M, Gu Y, Wang F, Shu Y, Yang Y, Sun L, Liu Y. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression. Front Immunol 2021;12:691879. [PMID: 34163488 DOI: 10.3389/fimmu.2021.691879] [Reference Citation Analysis]
52 Lai Y, Han T, Lao Z, Li G, Xiao J, Liu X. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis. Front Pharmacol 2021;12:754241. [PMID: 34803696 DOI: 10.3389/fphar.2021.754241] [Reference Citation Analysis]
53 Singh AK, Kasarpalkar N, Bhowmick S, Paradkar G, Talreja M, Shah K, Tiwari A, Palav H, Kaginkar S, Kulkarni R, Patil A, Kalsurkar V, Agrawal S, Shastri J, Dere R, Bharmal R, Mahale SD, Bhor VM, Patel V. Opposing roles for sMAdCAM and IL‐15 in COVID‐19 associated cellular immune pathology. J Leukocyte Bio. [DOI: 10.1002/jlb.3covbcr0621-300r] [Reference Citation Analysis]
54 Lorkiewicz P, Waszkiewicz N. Biomarkers of Post-COVID Depression. J Clin Med 2021;10:4142. [PMID: 34575258 DOI: 10.3390/jcm10184142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Metzemaekers M, Cambier S, Blanter M, Vandooren J, de Carvalho AC, Malengier-Devlies B, Vanderbeke L, Jacobs C, Coenen S, Martens E, Pörtner N, Vanbrabant L, Van Mol P, Van Herck Y, Van Aerde N, Hermans G, Gunst J, Borin A, Toledo N Pereira B, Dos Sp Gomes AB, Primon Muraro S, Fabiano de Souza G, S Farias A, Proenca-Modena JL, R Vinolo MA, Marques PE, Wouters C, Wauters E, Struyf S, Matthys P, Opdenakker G, Marques RE, Wauters J, Gouwy M, Proost P; CONTAGIOUS Consortium. Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019. Clin Transl Immunology 2021;10:e1271. [PMID: 33968405 DOI: 10.1002/cti2.1271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Sarohan AR, Kızıl M, İnkaya AÇ, Mahmud S, Akram M, Cen O. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signal 2021;87:110121. [PMID: 34438017 DOI: 10.1016/j.cellsig.2021.110121] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Park SH. An Impaired Inflammatory and Innate Immune Response in COVID-19. Mol Cells 2021;44:384-91. [PMID: 34098591 DOI: 10.14348/molcells.2021.0068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kessel C, Vollenberg R, Masjosthusmann K, Hinze C, Wittkowski H, Debaugnies F, Nagant C, Corazza F, Vély F, Kaplanski G, Girard-Guyonvarc'h C, Gabay C, Schmidt H, Foell D, Tepasse PR. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers. Arthritis Rheumatol 2021. [PMID: 33880885 DOI: 10.1002/art.41763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Hamed ME, Naeem A, Alkadi H, Alamri AA, AlYami AS, AlJuryyan A, Alturaiki W, Enani M, Al-Shouli ST, Assiri AM, Alosaimi B. Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality. J Clin Immunol 2021. [PMID: 34232441 DOI: 10.1007/s10875-021-01061-z] [Reference Citation Analysis]
60 Acevedo N, Escamilla-Gil JM, Espinoza H, Regino R, Ramírez J, Florez de Arco L, Dennis R, Torres-Duque CA, Caraballo L. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19. Front Immunol 2021;12:678661. [PMID: 34335580 DOI: 10.3389/fimmu.2021.678661] [Reference Citation Analysis]
61 de Almeida Chuffa LG, Freire PP, Dos Santos Souza J, de Mello MC, de Oliveira Neto M, Carvalho RF. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations. J Mol Med (Berl) 2021. [PMID: 34741638 DOI: 10.1007/s00109-021-02161-4] [Reference Citation Analysis]
62 Dalekos GN, Stefos A, Georgiadou S, Lygoura V, Michail A, Ntaios G, Samakidou A, Giannoulis G, Gabeta S, Vlychou M, Petinaki E, Leventogiannis K, Giamarellos-Bourboulis EJ, Gatselis NK. Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19. Eur J Intern Med 2021;88:52-62. [PMID: 33820686 DOI: 10.1016/j.ejim.2021.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Martinez Mesa A, Cabrera César E, Martín-Montañez E, Sanchez Alvarez E, Lopez PM, Romero-Zerbo Y, Garcia-Fernandez M, Velasco Garrido JL. Acute Lung Injury Biomarkers in the Prediction of COVID-19 Severity: Total Thiol, Ferritin and Lactate Dehydrogenase. Antioxidants (Basel) 2021;10:1221. [PMID: 34439469 DOI: 10.3390/antiox10081221] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Zhao B, Lu R, Chen J, Xie M, Zhao X, Kong L. S100A9 blockade prevents lipopolysaccharide-induced lung injury via suppressing the NLRP3 pathway. Respir Res 2021;22:45. [PMID: 33549095 DOI: 10.1186/s12931-021-01641-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Luporini RL, Rodolpho JMA, Kubota LT, Martin ACBM, Cominetti MR, Anibal FF, Pott-Junior H. IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19. Cytokine 2021;143:155507. [PMID: 33839002 DOI: 10.1016/j.cyto.2021.155507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Greenway A, Leahy N, Torrieri L, An A, Fink SA, Witenko C, Shikar M, Winchell RJ, Barie PS, Liu SI. Skin Failure Among Critically Ill Patients Afflicted with Coronavirus Disease 2019 (COVID-19). J Intensive Care Med 2021;36:1331-9. [PMID: 34591701 DOI: 10.1177/08850666211046532] [Reference Citation Analysis]
68 Fanning SL, Korngold R, Yang Z, Goldgirsh K, Park S, Zenreich J, Baker M, McKiernan P, Tan M, Zhang B, Donato ML, Perlin DS. Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma. PLoS Pathog 2021;17:e1010025. [PMID: 34714894 DOI: 10.1371/journal.ppat.1010025] [Reference Citation Analysis]
69 Pons MJ, Ymaña B, Mayanga-Herrera A, Sáenz Y, Alvarez-Erviti L, Tapia-Rojas S, Gamarra R, Blanco AB, Moncunill G, Ugarte-Gil MF. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort. Front Immunol 2021;12:700921. [PMID: 34539631 DOI: 10.3389/fimmu.2021.700921] [Reference Citation Analysis]
70 Alladina JW, Giacona FL, White EB, Brait KL, Abe EA, Michelhaugh SA, Hibbert KA, Januzzi JL, Thompson BT, Cho JL, Medoff BD. Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure. Crit Care Explor 2021;3:e0480. [PMID: 34235459 DOI: 10.1097/CCE.0000000000000480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sagris D, Florentin M, Tasoudis P, Korompoki E, Gatselis N, Giamarellos-Bourboulis EJ, Milionis H, Douketis J, Spyropoulos AC, Dalekos G, Ntaios G. Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials. J Clin Med 2021;10:5366. [PMID: 34830648 DOI: 10.3390/jcm10225366] [Reference Citation Analysis]
72 Gil-etayo FJ, Garcinuño S, Utrero-rico A, Cabrera-marante O, Arroyo-sanchez D, Mancebo E, Pleguezuelo DE, Rodríguez-frías E, Allende LM, Morales-pérez P, Castro-panete MJ, Lalueza A, Lumbreras C, Paz-artal E, Serrano A. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution. Biomedicines 2022;10:296. [DOI: 10.3390/biomedicines10020296] [Reference Citation Analysis]
73 Monserrat J, Asunsolo A, Gómez-Lahoz A, Ortega MA, Gasalla JM, Gasulla Ó, Fortuny-Profitós J, Mazaira-Font FA, Teixidó Román M, Arranz A, Sanz J, Muñoz B, Arévalo-Serrano J, Rodríguez JM, Martínez-A C, Balomenos D, Álvarez-Mon M. Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19. Biomedicines 2021;9:1675. [PMID: 34829906 DOI: 10.3390/biomedicines9111675] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kim I, Yoon S, Kim M, Lee H, Park S, Kim W, Lee S. Aspirin Is Related to Worse Clinical Outcomes of COVID-19. Medicina (Kaunas) 2021;57:931. [PMID: 34577854 DOI: 10.3390/medicina57090931] [Reference Citation Analysis]
75 Opdenakker G, Van Damme J. Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity. Cytokine Growth Factor Rev 2021;58:134-40. [PMID: 33563543 DOI: 10.1016/j.cytogfr.2021.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Gelzo M, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, Scialò F, Comegna M, Mormile M, Fabbrocini G, Parrella R, Corso G, Gentile I, Castaldo G. Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients. Sci Rep 2022;12:1212. [PMID: 35075175 DOI: 10.1038/s41598-021-04677-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
77 Tangye SG, Bucciol G, Meyts I. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity. Curr Opin Allergy Clin Immunol 2021;21:515-24. [PMID: 34494617 DOI: 10.1097/ACI.0000000000000786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Perpiñan C, Bertran L, Terra X, Aguilar C, Binetti J, Lopez-dupla M, Rull A, Reverté L, Yeregui E, Gómez-bertomeu F, Peraire J, Auguet T; on behalf of COVID-19 Study Group. Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome. JPM 2022;12:391. [DOI: 10.3390/jpm12030391] [Reference Citation Analysis]
79 Day JD, Park S, Ranard BL, Singh H, Chow CC, Vodovotz Y. Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model. Front Immunol 2021;12:754127. [PMID: 34777366 DOI: 10.3389/fimmu.2021.754127] [Reference Citation Analysis]
80 Sharma RK, Goswami B, Das Mandal S, Guha A, Willard B, Ray PS. Quorum Sensing by Gelsolin Regulates Programmed Cell Death 4 Expression and a Density-Dependent Phenotype in Macrophages. J Immunol 2021;207:1250-64. [PMID: 34362832 DOI: 10.4049/jimmunol.2001392] [Reference Citation Analysis]
81 De Winter FHR, Hotterbeekx A, Huizing MT, Konnova A, Fransen E, Jongers B, Jairam RK, Van Averbeke V, Moons P, Roelant E, Le Blon D, Vanden Berghe W, Janssens A, Lybaert W, Croes L, Vulsteke C, Malhotra-Kumar S, Goossens H, Berneman Z, Peeters M, van Dam PA, Kumar-Singh S. Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients. Cancers (Basel) 2021;13:5718. [PMID: 34830872 DOI: 10.3390/cancers13225718] [Reference Citation Analysis]
82 Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z. IMMUNOLOGICAL INSIGHTS INTO THE THERAPEUTIC ROLES OF CD24Fc AGAINST SEVERE COVID-19. medRxiv 2021:2021. [PMID: 34462760 DOI: 10.1101/2021.08.18.21262258] [Reference Citation Analysis]
83 Francis ME, Goncin U, Kroeker A, Swan C, Ralph R, Lu Y, Etzioni AL, Falzarano D, Gerdts V, Machtaler S, Kindrachuk J, Kelvin AA. SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney. PLoS Pathog 2021;17:e1009705. [PMID: 34265022 DOI: 10.1371/journal.ppat.1009705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Fava VM, Bourgey M, Nawarathna PM, Orlova M, Cassart P, Vinh DC, Cheng MP, Bourque G, Schurr E, Langlais D. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19. Sci Adv 2022;8:eabm2510. [PMID: 35648852 DOI: 10.1126/sciadv.abm2510] [Reference Citation Analysis]
85 Maecker HT. Immune profiling of COVID-19: preliminary findings and implications for the pandemic. J Immunother Cancer 2021;9:e002550. [PMID: 33963016 DOI: 10.1136/jitc-2021-002550] [Reference Citation Analysis]
86 Jasenovec T, Radosinska D, Kollarova M, Balis P, Dayar E, Bernatova I, Zorad S, Vrbjar N, Cacanyova S, Radosinska J. Angiotensin System Modulations in Spontaneously Hypertensive Rats and Consequences on Erythrocyte Properties; Action of MLN-4760 and Zofenopril. Biomedicines 2021;9:1902. [PMID: 34944718 DOI: 10.3390/biomedicines9121902] [Reference Citation Analysis]
87 Cani E, Dwivedi DJ, Liaw KL, Fraser DD, Yeh CH, Martin C, Slessarev M, Cerroni SE, Fox-Robichaud AA, Weitz JI, Kim PY, Liaw PC. Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality. Crit Care Explor 2021;3:e0588. [PMID: 34984340 DOI: 10.1097/CCE.0000000000000588] [Reference Citation Analysis]
88 Halim C, Mirza AF, Sari MI. The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis. Pathogens 2022;11:195. [DOI: 10.3390/pathogens11020195] [Reference Citation Analysis]
89 Momeni-Boroujeni A, Mendoza R, Stopard IJ, Lambert B, Zuretti A. A Dynamic Bayesian Model for Identifying High-Mortality Risk in Hospitalized COVID-19 Patients. Infect Dis Rep 2021;13:239-50. [PMID: 33803753 DOI: 10.3390/idr13010027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Tovo PA, Garazzino S, Daprà V, Pruccoli G, Calvi C, Mignone F, Alliaudi C, Denina M, Scolfaro C, Zoppo M, Licciardi F, Ramenghi U, Galliano I, Bergallo M. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases. Int J Mol Sci 2021;22:7481. [PMID: 34299101 DOI: 10.3390/ijms22147481] [Reference Citation Analysis]
91 Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha FQ, Alves-Filho JC, Cunha TM, Ekins S. Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice. bioRxiv 2021:2021. [PMID: 34981062 DOI: 10.1101/2021.12.16.472155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]